- Home
- ALTO vs DERM Comparison
ALTO vs DERM Comparison
Compare ALTO & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALTO | DERM |
|---|---|---|
| Founded | 2003 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 194.1M | 210.0M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | ALTO | DERM |
|---|---|---|
| Price | $2.69 | $8.03 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $5.50 | ★ $12.67 |
| AVG Volume (30 Days) | ★ 1.3M | 129.3K |
| Earning Date | 03-04-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $922,309,000.00 | $59,399,000.00 |
| Revenue This Year | N/A | $17.48 |
| Revenue Next Year | $8.07 | $55.83 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 2.82 |
| 52 Week Low | $0.76 | $3.54 |
| 52 Week High | $3.18 | $9.40 |
Technical Indicators
Market Signals| Indicator | ALTO | DERM |
|---|---|---|
| Relative Strength Index (RSI) | 54.94 | 53.99 |
| Support Level | $2.35 | $7.15 |
| Resistance Level | $2.76 | $8.40 |
| Average True Range (ATR) | 0.19 | 0.41 |
| MACD | -0.03 | 0.08 |
| Stochastic Oscillator | 51.45 | 72.03 |
Price Performance
Historical ComparisonAbout ALTO Alto Ingredients Inc.
Alto Ingredients Inc is a producer of specialty alcohols and essential ingredients. The company serves five markets: Health, Home and Beauty, Food and Beverage, Essential Ingredients, and Renewable Fuels. Its customers include food and beverage companies and consumer products manufacturers and distributors. The company operates under four segments: Marketing and distribution, Pekin Campus production, Western production, and Corporate.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.